| Medicare WPS | Billing and Coding: MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia (59121) | |
| Medicare WPS | Billing and Coding: MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma (59429) | |
| Medicare WPS | Billing and Coding: MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers (59549) | |
| Medicare WPS | Billing and Coding: MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy (59551) | |
| Medicare WPS | Billing and Coding: MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules (59560) | |
| Medicare WPS | MolDX: Clarification of Order Requirements for Laboratory and Molecular Diagnostic services (59798) | |
| Medicare WPS | Billing and Coding: Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC) (60213) | |
| Medicare WPS | Billing and Coding: MolDX: Molecular Testing for Solid Organ Allograft Rejection (60273) | |
| Medicare WPS | Billing and Coding: Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) (60276) | |
| Medicare WPS | Billing and Coding: MolDX: Biomarker Testing for Risk Stratification in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis (60305) | |